Stock Research: Fleury

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Fleury

BOVESPA:FLRY3 BRFLRYACNOR5
80
  • Value
    92
  • Growth
    85
  • Safety
    Safety
    44
  • Combined
    100
  • Sentiment
    16
  • 360° View
    360° View
    80
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Fleury SA is a Brazil-based medical laboratory services company. It operates in patient service centers (private medical diagnostics), B2B (clinical analysis and diagnostic imaging for partners), and dental diagnosis. Popular brands include Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax, and Inlab. The company primarily operates throughout Brazil. In the last fiscal year, the company had 22900 employees, a market cap of $1268 million, profits of $347 million, and revenue of $1244 million.

more
Index
BOVESPA
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
92 98 88 95
Growth
85 44 99 33
Safety
Safety
44 34 16 30
Sentiment
16 40 74 76
360° View
360° View
80 62 90 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
22 23 45 7
Opinions Change
11 15 75 83
Pro Holdings
n/a 60 30 56
Market Pulse
47 93 97 81
Sentiment
16 40 74 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
92 98 88 95
Growth
85 44 99 33
Safety Safety
44 34 16 30
Combined
100 79 92 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
84 95 84 83
Price vs. Earnings (P/E)
85 91 82 87
Price vs. Book (P/B)
78 86 73 70
Dividend Yield
96 96 85 96
Value
92 98 88 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
48 21 83 55
Profit Growth
23 77 87 75
Capital Growth
91 93 87 28
Stock Returns
93 18 69 11
Growth
85 44 99 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
12 13 10 6
Refinancing
89 94 64 82
Liquidity
25 17 14 25
Safety Safety
44 34 16 30

Similar Stocks

Discover high‑ranked alternatives to Fleury and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Lojas Renner

BOVESPA:LREN3
Country: Brazil
Industry: Apparel Retail
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a mixed bag with good value and high growth balanced by risky financing and negative sentiment. This is a risky stock that requires conviction; you should only consider it if you are willing to conduct further research into the underlying sentiment and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: